Fabrus Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

Fabrus General Information

Description

Provider of therapeutic antibody discovery and development platform intended to identify high-throughput biologic lead easily. The company's platform offers cell-based discoveries that allow direct screening for antibody leads on intact cells includes ultralong CDR3 antibodies and the chimerasome nanocage, enabling researchers to generate antibodies against very difficult, therapeutically important cell surface receptors.

Contact Information

Website
www.fabrus.net
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 230
  • San Diego, CA 92037
  • United States
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Acquirer
Sevion Therapeutics
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 230
  • San Diego, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fabrus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 19-May-2014 Completed Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Accelerator/Incubator 18-Jul-2007 Completed Generating Revenue
To view Fabrus’s complete valuation and funding history, request access »

Fabrus Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Fabrus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160168231-A1 Antibodies with ultralong complementarity determining regions Inactive 18-Jul-2013
EP-3022224-A2 Antibodies with ultralong complementarity determining regions Inactive 18-Jul-2013
US-20200181241-A1 Ultralong complementarity determining regions and uses thereof Active 09-Jan-2012
US-20150011431-A1 Humanized antibodies Inactive 09-Jan-2012
US-10774132-B2 Ultralong complementarity determining regions and uses thereof Active 09-Jan-2012 C07K16/00
To view Fabrus’s complete patent history, request access »

Fabrus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fabrus Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
OPKO Health Corporation Minority
Pfizer Corporation Minority
Pond Capital Venture Capital Minority
To view Fabrus’s complete investors history, request access »

Ready to get started?

Request a free trial

Fabrus FAQs

  • When was Fabrus founded?

    Fabrus was founded in 2007.

  • Who is the founder of Fabrus?

    Vaughn Smider Ph.D is the founder of Fabrus.

  • Where is Fabrus headquartered?

    Fabrus is headquartered in San Diego, CA.

  • What is the size of Fabrus?

    Fabrus has 5 total employees.

  • What industry is Fabrus in?

    Fabrus’s primary industry is Other Healthcare Services.

  • Is Fabrus a private or public company?

    Fabrus is a Private company.

  • What is Fabrus’s current revenue?

    The current revenue for Fabrus is .

  • Who are Fabrus’s investors?

    OPKO Health, Pfizer, and Pond Capital have invested in Fabrus.

  • When was Fabrus acquired?

    Fabrus was acquired on 19-May-2014.

  • Who acquired Fabrus?

    Fabrus was acquired by Sevion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »